Global Animal Microbiome Market: Research and Development Investment expected to enhance product development and insights in growing pet digestive hea

Animal Microbiomes are the communities of microorganisms such as viruses, bacteria, and fungi that symbiotically live around, on, and in animals which contribute to animal well-being and health. Microbiomes in animals are essential to maintaining the healthy function of their diverse ecosystems. Animal Microbiomes finds a vital range of application in Poultry, Ruminants, Swine, Aquaculture, and Pets.
The worldwide poultry and cattle population is expected to increase significantly in the coming years. In 2019, According to a USDA Foreign Agricultural Service estimate, the world cattle inventory was expected to be around 1,001,841,000. The market is principally driven by an increase in livestock population, with the domestic animal trend being particularly significant in developing nations such as China, India, and Brazil. In recent years, there has been a rapid surge in research and development in the animal microbiome business and increased awareness of antibiotic-free animal-derived products for animal health and welfare, which has created considerable market opportunities in the coming years. In July 2021, To accelerate the introduction of new products and insights in the pet microbiome modulation space, Cargill announced an investment in AnimalBiome, the Oakland, California-based start-up using the latest microbiome science to restore pet digestive and skin issues. A healthy gut microbiome (the digestive system and how it processes food for nutrition and energy) has been linked to general health and lifespan in studies.

Companies Mentioned: 

• Animal Biome, Inc.
• ANIZOME LLC
• Cargill
• Hansen Holding A/S
• Cytophage Technologies Inc.
• DuPont Industrial Biosciences
• Elanco Animal Health
• EnBiotix, Inc.
• Gnubiotics Sciences SA
• Hill's Pet Nutrition, Inc.
• Intralytix
• Koninklijke DSM N.V. (Royal DSM)
• Lallemand Inc.
• Land O'Lakes, Inc.
• Leiber GmbH
• MicroSintesis
• NomNomNow Inc.
• Novozymes A/S
• Orion Pharma Animal Health
• Phage Technologies SA
• Phagelux, Inc.
• Phibro Animal Health Corporation
• ProDigest
• Tonisity International Limited
• VetoPhage
• Other Prominent Players

Market Segments

Global Animal Microbiome Market, by Product, 2019-2030 (Value US$ Mn)

• Therapeutic/Pharma Products
• Animal Microbiome Product
• Functional Food
  • Glycan/Polysaccharide
  • FOS & MOS
  • Probiotics
  • Prebiotics
• Medical Food
• Dietary Supplement

Global Animal Microbiome Market, by Application, 2019-2030 (Value US$ Mn)

• Poultry
• Ruminants
• Swine
• Aquaculture
• Pets

Global Animal Microbiome Market, by Region, 2019-2030 (Value US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Animal Microbiome Market, by Country, 2019-2030 (Value US$ Mn)

• U.S.
• Canada

Europe Animal Microbiome Market, by Country, 2019-2030 (Value US$ Mn)

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Animal Microbiome Market, by Country, 2019-2030 (Value US$ Mn)

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Animal Microbiome Market, by Country, 2019-2030 (Value US$ Mn)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Animal Microbiome Market, by Country, 2019-2030 (Value US$ Mn)

• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:

• To receive a comprehensive analysis of the prospects for the global Animal Microbiome market
• To receive an industry overview and future trends of the Animal Microbiome market
• To analyze the Animal Microbiome market drivers and challenges
• To get information on the Animal Microbiome market size (Value US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the Animal Microbiome market industry